In mouse model, Weill Cornell researchers use gene therapy to correct deadly inherited immune disorder

Previous attempts in mice to correct a rare inherited immune disorder, called Hyper IgM X-linked immunodeficiency, have failed because standard gene therapy raised risks for cancer. Now Weill Cornell Medical College researchers believe they've found a way around that problem.

Cornell and Bassett Hospital researchers discover biological reason for obese mothers abandoning breast-feeding early

Studies have shown that overweight and obese mothers are significantly more likely to quit breast-feeding their infants sooner than do healthy-weight mothers. An important reason why is the weaker biological response that heavier women have to their babies' suckling, according to a study conducted.

Phase i clinical trial of monoclonal antibody treatment for advanced prostate cancer demonstrates evidence of anti-tumor activity

Researchers at NewYork-Presbyterian/Weill Cornell Report Findings of Phase I Clinical Trial of Monoclonal Antibody Treatment for Advanced Prostate Cancer.

Weill Cornell launches new stem cell center with $15 million grant

The Board of Overseers of Weill Cornell Medical College in New York City voted today to establish the new Ansary Center for Stem Cell Therapeutics. The unique Center will bring together a premier team of scientists to focus on stem cells – the primitive, unspecialized cells thought to have an unrivaled capacity to form all types of cells in the body.

New York-Presbyterian/Weill Cornell researchers discover non-protease inhibitor drug combo better than others for fighting HIV

A certain combination of AIDS drugs is superior to others when it comes to the initial treatment of HIV patients, NewYork-Presbyterian Hospital/Weill Cornell Medical Center researchers report in the New England Journal of Medicine.

First successful embryo biopsy for deadly genetic cancer -- retinoblastoma

In a significant scientific achievement, physicians and scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have successfully employed preimplantation genetic diagnosis for retinoblastoma, resulting in the world's first babies born free of the deadly eye cancer. The news appears in this month's issue of the American Journal of Ophthalmology.

New York Weill Cornell discovers anti-cancer drug tamoxifen boosts fertility in breast cancer patients

The Center for Reproductive Medicine and Infertility at NewYork Weill Cornell Medical Center has discovered that the wonder drug tamoxifen can help breast cancer patients have babies - even after they experience fertility loss associated with chemotherapy.

Jean W. Pape receives French Legion of Honor for two decades of outstanding service to health in Haiti

Dr. Jean W. Pape, an internationally recognized infectious disease expert and Professor of Medicine at Weill Cornell Medical College, has received France's highest distinction, the Legion d'Honneur, for his more-than-two-decades of work fighting disease in his native Haiti.

Asians' switch to Western diet might bring Western-type diseases, new China-Taiwan study suggests

The long-term health benefits to Chinese and other Asian people who have traditionally existed on a primarily plant-based diet might be lost as more people in Asia switch to a Western-style diet that is rich in animal-based foods.